• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潜在 COPD 发病过程中 FEV 时间特征的研究:使用日本体检数据的回顾性队列研究。

Investigation of time profile of FEV across the onset of potential COPD: a retrospective cohort study using medical checkup data in Japan.

机构信息

Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan.

Department of Respiratory, Inflammation, and Autoimmune, Medical, AstraZeneca K.K., Osaka, Japan.

出版信息

Sci Rep. 2023 Apr 3;13(1):5454. doi: 10.1038/s41598-023-32205-3.

DOI:10.1038/s41598-023-32205-3
PMID:37012340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10070435/
Abstract

This study compared the time profile of FEV after COPD diagnosis among rapid decliners, slow decliners, and sustainers in the year of COPD diagnosis. COPD subjects were identified from the annual medical checkup records of Hitachi, Ltd., employees in Japan (April 1998-March 2019). Subjects were categorized into 3 groups (rapid decliner [decrease of FEV ≥ 63 mL/year], slow decliner [< 63 and ≥ 31 mL/year], and sustainer [< 31 mL/year]) for 5 years. The time profile of FEV was compared using mixed-effects model for 5 years after diagnosis; risk factors of rapid decliner were detected using logistic model/gradient boosting decision tree. Of 1294 eligible subjects, 18.6%, 25.7%, and 55.7% were classified as rapid decliners, slow decliners, and sustainers, respectively. The annual rates of FEV decline were similar 3 years before and until COPD diagnosis. The mean FEV in rapid decliners was 2.82 ± 0.04 L in year 0 and 2.41 ± 0.05 L in year 5, and in sustainers, it was 2.67 ± 0.02 L and 2.72 ± 0.02 L (year 0, p = 0.0004). In conclusion, FEV declined yearly before diagnosis and the time profiles of FEV were different in the 3 groups after COPD diagnosis. Therefore, appropriate treatment of the 3 groups with regular lung function tests is necessary to follow FEV decline after COPD onset.

摘要

这项研究比较了在 COPD 诊断当年,快速下降组、缓慢下降组和稳定组的 FEV 时间曲线。COPD 患者是从日本日立公司(1998 年 4 月至 2019 年 3 月)年度体检记录中确定的。患者被分为 3 组(快速下降组[FEV 下降≥63mL/年]、缓慢下降组[<63 且≥31mL/年]和稳定组[<31mL/年]),随访 5 年。使用混合效应模型比较诊断后 5 年内的 FEV 时间曲线;使用逻辑模型/梯度提升决策树检测快速下降的危险因素。在 1294 名合格的患者中,18.6%、25.7%和 55.7%分别归类为快速下降组、缓慢下降组和稳定组。诊断前 3 年和直至 COPD 诊断,FEV 下降的年率相似。快速下降组患者的 FEV 平均值在第 0 年为 2.82±0.04L,在第 5 年为 2.41±0.05L,而稳定组患者在第 0 年为 2.67±0.02L,在第 5 年为 2.72±0.02L(第 0 年,p=0.0004)。总之,在诊断前 FEV 每年下降,并且在 COPD 诊断后 3 组的 FEV 时间曲线不同。因此,对这 3 组患者进行定期肺功能检查并跟踪 COPD 发病后 FEV 的下降情况,进行适当的治疗是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4f/10070435/0074b9fa53c5/41598_2023_32205_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4f/10070435/be9077d70a9d/41598_2023_32205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4f/10070435/f78bd7459e1f/41598_2023_32205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4f/10070435/0074b9fa53c5/41598_2023_32205_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4f/10070435/be9077d70a9d/41598_2023_32205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4f/10070435/f78bd7459e1f/41598_2023_32205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4f/10070435/0074b9fa53c5/41598_2023_32205_Fig3_HTML.jpg

相似文献

1
Investigation of time profile of FEV across the onset of potential COPD: a retrospective cohort study using medical checkup data in Japan.潜在 COPD 发病过程中 FEV 时间特征的研究:使用日本体检数据的回顾性队列研究。
Sci Rep. 2023 Apr 3;13(1):5454. doi: 10.1038/s41598-023-32205-3.
2
Risk Factors of Rapid FEV1 Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort.真实世界慢性阻塞性肺疾病队列中快速 FEV1 下降的危险因素。
Respiration. 2022;101(12):1078-1087. doi: 10.1159/000525871. Epub 2022 Nov 4.
3
FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.慢性阻塞性肺疾病患者因生物质暴露导致的 FEV1 下降。
Am J Respir Crit Care Med. 2014 Nov 1;190(9):996-1002. doi: 10.1164/rccm.201404-0720OC.
4
Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的肺功能和临床表型的年度变化。
Am J Respir Crit Care Med. 2012 Jan 1;185(1):44-52. doi: 10.1164/rccm.201106-0992OC.
5
Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者5年期间生活质量各组成部分的差异变化。
Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:745-57. doi: 10.2147/COPD.S77586. eCollection 2015.
6
Machine Learning Methods for the Diagnosis of Chronic Obstructive Pulmonary Disease in Healthy Subjects: Retrospective Observational Cohort Study.用于健康受试者慢性阻塞性肺疾病诊断的机器学习方法:回顾性观察队列研究
JMIR Med Inform. 2021 Jul 6;9(7):e24796. doi: 10.2196/24796.
7
Bacterial load and related innate immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease.慢性阻塞性肺疾病快速下降者支气管内细菌负荷及相关固有免疫反应。
Respir Med. 2023 Aug-Sep;215:107297. doi: 10.1016/j.rmed.2023.107297. Epub 2023 May 27.
8
Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease.慢性阻塞性肺疾病快速下降者的支气管中体液免疫应答降低。
Respir Res. 2022 Aug 3;23(1):200. doi: 10.1186/s12931-022-02125-3.
9
Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.慢性阻塞性肺疾病中急性加重对通过强迫振荡技术测量的呼吸系统阻抗的影响:一项前瞻性观察研究。
Int J Chron Obstruct Pulmon Dis. 2017 Feb 3;12:509-516. doi: 10.2147/COPD.S124828. eCollection 2017.
10
Age-related annual decline of lung function in patients with COPD.慢性阻塞性肺疾病(COPD)患者肺功能随年龄增长的年度下降情况。
Int J Chron Obstruct Pulmon Dis. 2015 Dec 30;11:51-60. doi: 10.2147/COPD.S95028. eCollection 2016.

引用本文的文献

1
Trajectory of the arterial-alveolar oxygen gradient in COPD for a decade.慢性阻塞性肺疾病(COPD)患者动脉-肺泡氧梯度十年变化轨迹
PLoS One. 2025 Jan 29;20(1):e0318377. doi: 10.1371/journal.pone.0318377. eCollection 2025.

本文引用的文献

1
Machine Learning Methods for the Diagnosis of Chronic Obstructive Pulmonary Disease in Healthy Subjects: Retrospective Observational Cohort Study.用于健康受试者慢性阻塞性肺疾病诊断的机器学习方法:回顾性观察队列研究
JMIR Med Inform. 2021 Jul 6;9(7):e24796. doi: 10.2196/24796.
2
Assessing Missing Data Assumptions in EHR-Based Studies: A Complex and Underappreciated Task.评估基于电子健康记录(EHR)研究中的缺失数据假设:一项复杂且未得到充分重视的任务。
JAMA Netw Open. 2021 Feb 1;4(2):e210184. doi: 10.1001/jamanetworkopen.2021.0184.
3
Diagnosis and Treatment of Early Chronic Obstructive Lung Disease (COPD).
早期慢性阻塞性肺疾病(COPD)的诊断与治疗
J Clin Med. 2020 Oct 26;9(11):3426. doi: 10.3390/jcm9113426.
4
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review.慢性阻塞性肺疾病(COPD)经济负担:系统文献回顾。
Int J Chron Obstruct Pulmon Dis. 2020 Feb 26;15:439-460. doi: 10.2147/COPD.S234942. eCollection 2020.
5
BMI is associated with FEV decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials.BMI 与慢性阻塞性肺疾病的 FEV 下降相关:临床试验的荟萃分析。
Respir Res. 2019 Oct 29;20(1):236. doi: 10.1186/s12931-019-1209-5.
6
Longitudinal decline in lung function: a community-based cohort study in Korea.肺功能的纵向下降:韩国的一项基于社区的队列研究。
Sci Rep. 2019 Sep 20;9(1):13614. doi: 10.1038/s41598-019-49598-9.
7
New insights into early intervention of chronic obstructive pulmonary disease with mild airflow limitation.慢性阻塞性肺疾病轻度气流受限的早期干预新见解。
Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1119-1125. doi: 10.2147/COPD.S205382. eCollection 2019.
8
Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV (PURE): an international, community-based cohort study.FEV 受损个体的死亡率和心血管及呼吸道发病率(纯粹研究):一项国际社区为基础的队列研究。
Lancet Glob Health. 2019 May;7(5):e613-e623. doi: 10.1016/S2214-109X(19)30070-1.
9
Annual change in FEV in elderly 10-year survivors with established chronic obstructive pulmonary disease.老年慢性阻塞性肺疾病 10 年生存者的 FEV 年变化率。
Sci Rep. 2019 Feb 14;9(1):2073. doi: 10.1038/s41598-019-38659-8.
10
Relative and absolute lung function change in a general population aged 60-102 years.60-102 岁一般人群的肺功能相对和绝对变化。
Eur Respir J. 2019 Mar 14;53(3). doi: 10.1183/13993003.01812-2017. Print 2019 Mar.